Derya TÜLÜCE, Sevinç KUTLUTÜRKAN, Emine KAPLAN SERİN

Oral mucous membrane condition of the patients with chronic obstructive pulmonary disease and the measures taken for the protection

Aim: This study was carried out to evaluate the oral mucous membranes of patients with chronic obstructive pulmonary disease andto determine the measures taken for the protection of oral mucous membranes.Materials and Methods: This study was carried out as a descriptive and cross-sectional study. This study was carried out with200 patients admitted to the chest diseases polyclinic and clinic of a hospital. The patient information form, the “Oral Mucosa RiskAssessment Form" and the " Oral Evaluation Guide" were used in the evaluation of data.Results: A significant positive relationship was found between the mean score of oral mucosa risk assessment form and the meanscore of oral evaluation guide. A statistically significant positive relationship was found between the mean score of oral mucosa riskassessment form and the mean score of oral evaluation guide and age, year of disease and the duration of inhaler use.Conclusion: According to the results, it was observed that the oral care of COPD patients was moderate; however, they did not paysufficient attention to tooth brushing. Nursing approaches for the prevention of oral mucous membranes should be determined inpatients with chronic obstructive pulmonary disease.

PDF

___

1. Yildiz M, Durna Z, Akın S. The assessment of oral care needs of the patients treated at the intensive care unit. J Clin Nurs 2013;22:2734-47.
2. Christensen VL, Holm AM, Cooper B, et al. Differences in Symptom Burden Among Patients with Moderate, Severe, or Very Severe Chronic Obstructive Pulmonary Disease. J Pain Symptom Manage 2016;51:849-59.
3. Scully C, Ettinger RL. The influence of systemic disease on oral helath care in older adults. JADA 2007;138:9 supplement:7-14.
4. Rodrigue C, Beauchesne MF, Savaria F, et al. RESP Investigator. Adverse events among COPD patients treated with long-acting anticholinergics and β2- agonists in an outpatient respiratory clinic. Respir Med 2016;113:65-73.
5. Rennard S, Fogarty C, Reisner C, et al. Orevillo C. Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease. BMC PulmMed 2014;14:118.
6. Hira D, Koshiyama S, Komase Y, et al. Dry mouth as a novel indicator of hoarseness caused by inhalation therapy. J Asthma 2015;52:296-300.
7. Przybyłowska D, Rubinsztajn R, Chazan R, et al. The Prevalence of Oral Inflammation Among Denture Wearing Patients with Chronic Obstructive Pulmonary Disease. Adv Exp Med Biol 2015; 858:87-91.
8. Godara N, Godara R, Khullar M. Impact of inhalation therapy on oral health. Lung India 2011;28:4:272-5.
9. Yamamoto T, Fuchida S, Aida J, Kondo K, et al. Adult Oral Health Programs in Japanese Municipalities: Factors Associated with Self-Rated Effectiveness. Tohoku J ExpMed 2015; 237:259-66.
10. Almomani F, Hamasha AA, Williams KB, et al. Oral health status and physical, mental and cognitive disabilities among nursing home residents in Jordan. Gerodontology 2015;32:90-9.
11. Danckert R, Ryan A, Plummer V, et al. Hospitalisation impacts on oral hygiene: an audit of oral hygiene in a metropolitan health service. Scand J Caring Sci 2016; 30:129-34.
12. Saltnes SS, Storhaug K, Borge CR, et al. Oral healthrelated quality-of-life and mental health in individuals with chronic obstructive pulmonary disease (COPD). Acta Odontol Scand 2015;73:14-20.
13. Celik G, Kaya A, Ciledag A. Bronchodilator Treatment and Support Treatments in COPD. Thoracic Surgery Bulletin 2010;1:124-35.
14. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2018 report. Global initiative for chronic obstructive lung disease. Available from: https://goldcopd. org/wp-content/uploads/2017/11/GOLD-2018- v6.0-FINAL-revised-20-Nov_WMS.pdf (access 11 November 2018).
15. Dekhuijzen PNR, Batsiou M, Bjermer L, et al. Price DB. Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device. Respir Med 2016;120:54-63.
16. Bhavsar NV, Dave BD, Brahmbhatt NA, et al. Periodontal status and oral health behavior in hospitalized patients with chronic obstructive pulmonary disease. J Nat Sci Biol Med 2015;6:93-7.
17. Baldomero AK, Siddigui M, Lo CY, et al. The relationship between oral health and COPD exacerbations. Int J Chron Obstruct Pulmon Dis 2019;23:881-92.